295 related articles for article (PubMed ID: 23144574)
1. Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art.
Clemons M; Gelmon KA; Pritchard KI; Paterson AH
Curr Oncol; 2012 Oct; 19(5):259-68. PubMed ID: 23144574
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates and other bone agents for breast cancer.
Wong MH; Stockler MR; Pavlakis N
Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
4. [The treatment for cancer with bone metastases -whether to use zoledoronate or denosumab for bone metastases-].
Kohno N
Clin Calcium; 2014 Aug; 24(8):1229-36. PubMed ID: 25065876
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates for breast cancer.
Pavlakis N; Stockler M
Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Bone Metastases in Patients with Advanced Breast Cancer.
Gnant M; Balic M; Petru E; Raunik W; Singer CF; Steger GG; Watzke IM; Brodowicz T
Breast Care (Basel); 2012 Apr; 7(2):92-98. PubMed ID: 22740794
[TBL] [Abstract][Full Text] [Related]
7. Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors.
Brown-Glaberman U; Stopeck AT
Biologics; 2012; 6():89-99. PubMed ID: 22532777
[TBL] [Abstract][Full Text] [Related]
8. Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody.
von Moos R; Costa L; Gonzalez-Suarez E; Terpos E; Niepel D; Body JJ
Cancer Treat Rev; 2019 Jun; 76():57-67. PubMed ID: 31136850
[TBL] [Abstract][Full Text] [Related]
9. Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice.
Li BT; Wong MH; Pavlakis N
J Clin Med; 2014 Jan; 3(1):1-24. PubMed ID: 26237249
[TBL] [Abstract][Full Text] [Related]
10. Denosumab for the treatment of bone metastases in advanced breast cancer.
Casas A; Llombart A; Martín M
Breast; 2013 Oct; 22(5):585-92. PubMed ID: 23759273
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and safety of denosumab versus bisphosphonates in breast cancer and bone metastases treatment: A meta-analysis of randomized controlled trials.
Wang X; Yang KH; Wanyan P; Tian JH
Oncol Lett; 2014 Jun; 7(6):1997-2002. PubMed ID: 24932278
[TBL] [Abstract][Full Text] [Related]
12. Denosumab versus pamidronate in the treatment of osteolytic bone metastases secondary to breast cancer: a multi-institutional analysis.
Bradley M; Nichols M; Miles B
Proc (Bayl Univ Med Cent); 2024; 37(1):26-29. PubMed ID: 38174029
[TBL] [Abstract][Full Text] [Related]
13. Analysis of denosumab on skeletal-related events in patients with advanced breast cancer.
Bink KF
Clin J Oncol Nurs; 2015 Oct; 19(5):E108-14. PubMed ID: 26414586
[TBL] [Abstract][Full Text] [Related]
14. Denosumab: a new option in the treatment of bone metastases from urological cancers.
Yuasa T; Yamamoto S; Urakami S; Fukui I; Yonese J
Onco Targets Ther; 2012; 5():221-9. PubMed ID: 23055747
[TBL] [Abstract][Full Text] [Related]
15. Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases.
Lipton A; Steger GG; Figueroa J; Alvarado C; Solal-Celigny P; Body JJ; de Boer R; Berardi R; Gascon P; Tonkin KS; Coleman R; Paterson AH; Peterson MC; Fan M; Kinsey A; Jun S
J Clin Oncol; 2007 Oct; 25(28):4431-7. PubMed ID: 17785705
[TBL] [Abstract][Full Text] [Related]
16. "The use of bisphosphonates to treat skeletal complications in solid tumours".
D'Oronzo S; Wood S; Brown JE
Bone; 2021 Jun; 147():115907. PubMed ID: 33676057
[TBL] [Abstract][Full Text] [Related]
17. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.
Stopeck AT; Lipton A; Body JJ; Steger GG; Tonkin K; de Boer RH; Lichinitser M; Fujiwara Y; Yardley DA; Viniegra M; Fan M; Jiang Q; Dansey R; Jun S; Braun A
J Clin Oncol; 2010 Dec; 28(35):5132-9. PubMed ID: 21060033
[TBL] [Abstract][Full Text] [Related]
18. Denosumab: A comprehensive review.
Narayanan P
South Asian J Cancer; 2013 Oct; 2(4):272-7. PubMed ID: 24455656
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of denosumab versus bisphosphonates for the prevention of bone complications: implications for nursing.
Campbell-Baird C; Harrelson S; Frey G; Balakumaran A
Support Care Cancer; 2015 Dec; 23(12):3625-32. PubMed ID: 26298333
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
